Logo

Similar Products

Description

Methylprednisolone Sodium Succinate Injection 250 mg represents a premium pharmaceutical solution designed for medical professionals requiring reliable corticosteroid treatment. Th...
Methylprednisolone Sodium Succinate Injection 250 mg represents a premium pharmaceutical solution designed for medical professionals requiring reliable corticosteroid treatment. This medicine-grade liquid injection contains pure Methylprednisolone Sodium Succinate as the active ingredient, formulated to deliver precise therapeutic effects with consistent 250 mg dosage accuracy. The product undergoes stringent quality control measures to ensure purity and hygiene, meeting international pharmaceutical standards. Its liquid form allows for immediate administration and rapid systemic absorption, making it particularly effective in situations requiring quick anti-inflammatory and immunosuppressive action. The OEM supply model ensures healthcare providers receive solutions that align with their specific operational requirements and patient care protocols.

This injection finds extensive application across multiple healthcare sectors including hospitals, specialty clinics, and emergency care facilities. Rheumatology departments utilize it for managing severe inflammatory conditions like rheumatoid arthritis and lupus, while allergy specialists employ it for treating acute allergic reactions and asthma exacerbations. Transplant centers incorporate this medication in immunosuppressive regimens to prevent organ rejection. Emergency medicine professionals rely on its rapid action for treating anaphylactic shock and severe inflammatory responses. The product's consistent quality and reliability make it essential in pharmaceutical inventories across various medical specialties requiring immediate-acting corticosteroid solutions.

The value of Methylprednisolone Sodium Succinate Injection lies in its proven reliability and consistent therapeutic performance, which translates to enhanced patient outcomes and operational efficiency for healthcare providers. Medical distributors benefit from the OEM supply model that ensures product consistency and meets specific market requirements. The pure and hygienic formulation reduces contamination risks, ensuring patient safety and maintaining treatment efficacy. Its established track record in clinical settings builds trust among healthcare professionals, making it a preferred choice for serious medical applications. The injection's versatility across different medical specialties creates reliable treatment options while addressing critical healthcare needs in various patient care scenarios.

Key Features:
- Medicine-grade liquid formulation for immediate therapeutic effect
- Precise 250 mg dosage accuracy in every injection
- Pure and hygienic composition meeting pharmaceutical standards
- OEM supply type ensuring consistent quality
- Active ingredient Methylprednisolone Sodium Succinate

Benefits:
- Rapid anti-inflammatory and immunosuppressive action
- Consistent therapeutic performance across applications
- Enhanced patient safety through pure formulation
- Reliable solution for emergency and routine treatments
- Trusted by healthcare professionals worldwide

Specifications

Key Attributes
FormLiquid
FunctionNutritional Medicine
TypeInjection
UsageMedical
DosageUp to 250 mg
Supply TypeOEM
Dosage FormInjection
FeaturesPure and Hygenic
GradeMedicine Grade
Active IngredientMethylprednisolone Sodium Succinate
Additional Information
Country of Origin106
CustomisableNo

Application

Methylprednisolone Sodium Succinate Injection 250 mg serves as a critical anti-inflammatory and immunosuppressive medication in clinical environments. Healthcare professionals administer this precise liquid formulation to manage severe allergic reactions, autoimmune disorders, and inflammatory conditions requiring immediate therapeutic intervention. The medicine-grade product ensures rapid absorption and consistent performance across various medical specialties and treatment protocols.

This reliable OEM injection is particularly valuable in hospital settings, emergency care units, and specialty clinics where dosage accuracy and purity standards are paramount. Medical distributors and wholesalers supply this product to healthcare facilities seeking consistent quality pharmaceutical solutions. The 250 mg formulation addresses diverse therapeutic needs while maintaining strict hygiene and safety standards for patient care across multiple medical disciplines.
- Emergency treatment of severe allergic reactions and anaphylactic shock
- Management of autoimmune disorders including rheumatoid arthritis and lupus
- Immunosuppressive therapy for organ transplant patients
- Treatment of acute asthma exacerbations and respiratory inflammation
- Control of inflammatory conditions in hospital and critical care settings

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Mercury Medicare, Tamil Nadu
IndiaTamil Nadu, India
Health & Personal CareManufacturerDistributor / WholesalerImporter / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0
Main Markets
North America
Oceania
Eastern Asia
Western Europe

Medical OEM Injection Methylprednisolone Sodium Succinate 250 mg Pure

Medical OEM Injection Methylprednisolone Sodium Succinate 250 mg pure medicine-grade liquid formulation delivers precise anti-inflammatory and immunosuppressive treatment for healthcare facilities and clinical applications.

Min. Order Quantity: 100000 Pieces

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Mercury Medicare
Verified
IndiaTamil Nadu, India
Health & Personal CareManufacturer

More Products From Supplier

Related Products